1
|
Gajski G, Kašuba V, Milić M, Gerić M, Matković K, Delić L, Nikolić M, Pavičić M, Rozgaj R, Garaj-Vrhovac V, Kopjar N. Exploring cytokinesis block micronucleus assay in Croatia: A journey through the past, present, and future in biomonitoring of the general population. MUTATION RESEARCH. GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 2024; 895:503749. [PMID: 38575251 DOI: 10.1016/j.mrgentox.2024.503749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/05/2023] [Revised: 03/06/2024] [Accepted: 03/12/2024] [Indexed: 04/06/2024]
Abstract
In this study, we used the cytokinesis-block micronucleus (CBMN) assay to evaluate the background frequency of cytogenetic damage in peripheral blood lymphocytes of the general population concerning different anthropometric data and lifestyle factors. The background frequency of CBMN assay parameters was analysed in 850 healthy, occupationally non-exposed male and female subjects (average age, 38±11 years) gathered from the general Croatian population from 2000 to 2023. The mean background values for micronuclei (MNi) in the whole population were 5.3±4.3 per 1000 binucleated cells, while the mean frequency of nucleoplasmic bridges (NPBs) was 0.7±1.3 and of nuclear buds (NBUDs) 3.1±3.2. The cut-off value, which corresponds to the 95th percentile of the distribution of 850 individual values, was 14 MNi, 3 NPBs, and 9 NBUDs. Results from our database also showed an association of the tested genomic instability parameters with age and sex but also with other lifestyle factors. These findings underscore the importance of considering several anthropometric and lifestyle factors when conducting biomonitoring studies. Overall, the normal and cut-off values attained here present normal values for the general population that can later serve as baseline values for further human biomonitoring studies either in Croatia or worldwide.
Collapse
Affiliation(s)
- Goran Gajski
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia.
| | - Vilena Kašuba
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Mirta Milić
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Marko Gerić
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Katarina Matković
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Luka Delić
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Maja Nikolić
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Martina Pavičić
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Ružica Rozgaj
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Vera Garaj-Vrhovac
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| | - Nevenka Kopjar
- Institute for Medical Research and Occupational Health, Division of Toxicology, Mutagenesis Unit, 10000 Zagreb, Croatia
| |
Collapse
|
2
|
Nersesyan A, Kundi M, Fenech M, Stopper H, da Silva J, Bolognesi C, Mišík M, Knasmueller S. Recommendations and quality criteria for micronucleus studies with humans. MUTATION RESEARCH. REVIEWS IN MUTATION RESEARCH 2022; 789:108410. [PMID: 35690413 DOI: 10.1016/j.mrrev.2021.108410] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 12/15/2021] [Accepted: 12/17/2021] [Indexed: 06/15/2023]
Abstract
Micronucleus (MN) analyses in peripheral blood lymphocytes and exfoliated cells from different organs (mouth, nose, bladder and cervix) are at present the most widely used approaches to detect damage of genetic material in humans. MN are extranuclear DNA-containing bodies, which can be identified microscopically. They reflect structural and numerical chromosomal aberrations and are formed as a consequence of exposure to occupational, environmental and lifestyle genotoxins. They are also induced as a consequence of inadequate intake of certain trace elements and vitamins. High MN rates are associated with increased risk of cancer and a range of non-cancer diseases in humans. Furthermore, evidence is accumulating that measurements of MN could be a useful tool for the diagnosis and prognosis of different forms of cancer and other diseases (inflammation, infections, metabolic disorders) and for the assessment of the therapeutic success of medical treatments. Recent reviews of the current state of knowledge suggest that many clinical studies have methodological shortcomings. This could lead to controversial findings and limits their usefulness in defining the impact of exposure concentrations of hazardous chemicals, for the judgment of remediation strategies, for the diagnosis of diseases and for the identification of protective or harmful dietary constituents. This article describes important quality criteria for human MN studies and contains recommendations for acceptable study designs. Important parameters that need more attention include sufficiently large group sizes, adequate duration of intervention studies, the exclusion of confounding factors which may affect the results (sex, age, body mass index, nutrition, etc.), the evaluation of appropriate cell numbers per sample according to established scoring criteria as well as the use of proper stains and adequate statistical analyses.
Collapse
Affiliation(s)
- A Nersesyan
- Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria
| | - M Kundi
- Center for Public Health, Department of Environmental Health, Medical University of Vienna, Vienna, Austria
| | - M Fenech
- School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia; Universiti Kebangsaan Malaysia, Selangor, Malaysia; Genome Health Foundation, North Brighton, SA, Australia
| | - H Stopper
- Institute of Pharmacology and Toxicology, Wuerzburg University, Wuerzburg, Germany
| | - J da Silva
- Laboratory of Genetic Toxicology, Lutheran University of Brazil (ULBRA) & LaSalle University (UniLaSalle), Canoas, RS, Brazil
| | - C Bolognesi
- Environmental Carcinogenesis Unit, Ospedale Policlinico San Martino, Genoa, Italy
| | - M Mišík
- Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria
| | - S Knasmueller
- Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
| |
Collapse
|
3
|
Albertini RJ, Kaden DA. Mutagenicity monitoring in humans: Global versus specific origin of mutations. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2020; 786:108341. [PMID: 33339577 DOI: 10.1016/j.mrrev.2020.108341] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2020] [Revised: 10/08/2020] [Accepted: 10/14/2020] [Indexed: 01/19/2023]
Abstract
An underappreciated aspect of human mutagenicity biomonitoring is tissue specificity reflected in different assays, especially those that measure events that can only occur in developing bone marrow (BM) cells. Reviewed here are 9 currently-employed human mutagenicity biomonitoring assays. Several assays measure chromosome-level events in circulating T-lymphocytes (T-cells), i.e., traditional analyses of aberrations, translocation studies involving chromosome painting and fluorescence in situ hybridization (FISH) and determinations of micronuclei (MN). Other T-cell assays measure gene mutations. i.e., hypoxanthine-guanine phosphoriboslytransferase (HPRT) and phosphoribosylinositol glycan class A (PIGA). In addition to the T-cell assays, also reviewed are those assays that measure events in peripheral blood cells that necessarily arose in BM cells, i.e., MN in reticulocytes; glycophorin A (GPA) gene mutations in red blood cells (RBCs), and PIGA gene mutations in RBC or granulocytes. This review considers only cell culture- or cytometry-based assays to describe endpoints measured, methods, optimal sampling times, and sample summaries of typical quantitative and qualitative results. However, to achieve its intended focus on the target cells where events occur, kinetics of the cells of peripheral blood that derive at some point from precursor cells are reviewed to identify body sites and tissues where the genotoxic events originate. Kinetics indicate that in normal adults, measured events in T-cells afford global assessments of in vivo mutagenicity but are not specific for BM effects. Therefore, an agent's capacity for inducing mutations in BM cells cannot be reliably inferred from T-cell assays as the magnitude of effect in BM, if any, is unknown. By contrast, chromosome or gene level mutations measured in RBCs/reticulocytes or granulocytes must originate in BM cells, i.e. in RBC or granulocyte precursors, thereby making them specific indicators for effects in BM. Assays of mutations arising directly in BM cells may quantitatively reflect the mutagenicity of potential leukemogenic agents.
Collapse
Affiliation(s)
- Richard J Albertini
- University of Vermont, 111 Colchester Avenue, Burlington, VT 05401, United States
| | - Debra A Kaden
- Ramboll US Consulting, Inc., 101 Federal Street, Suite 1900, Boston, MA 02110, United States.
| |
Collapse
|
4
|
Aydın M, Arslan M, Rencüzoğulları E, Gözaydın C, Genç A, Bayram S. Investigation of XRCC1 Arg399Gln, Arg280His, and Arg194Trp polymorphisms effects on the induction of micronucleus by Aflatoxin B1 in in vitro. GENE REPORTS 2017. [DOI: 10.1016/j.genrep.2017.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
5
|
Bhagat J. Combinations of genotoxic tests for the evaluation of group 1 IARC carcinogens. J Appl Toxicol 2017; 38:81-99. [PMID: 28695982 DOI: 10.1002/jat.3496] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2017] [Revised: 05/17/2017] [Accepted: 05/17/2017] [Indexed: 01/10/2023]
Abstract
Many of the known human carcinogens are potent genotoxins that are efficiently detected as carcinogens in human populations but certain types of compounds such as immunosuppressants, sex hormones, etc. act via non-genotoxic mechanism. The absence of genotoxicity and the diversity of modes of action of non-genotoxic carcinogens make predicting their carcinogenic potential extremely challenging. There is evidence that combinations of different short-term tests provide a better and efficient prediction of human genotoxic and non-genotoxic carcinogens. The purpose of this study is to summarize the in vivo and in vitro comet assay (CMT) results of group 1 carcinogens selected from the International Agency for Research on Cancer and to discuss the utility of the comet assay along with other genotoxic assays such as Ames, in vivo micronucleus (MN), and in vivo chromosomal aberration (CA) test. Of the 62 agents for which valid genotoxic data were available, 38 of 61 (62.3%) were Ames test positive, 42 of 60 (70%) were in vivo MN test positive and 36 of 45 (80%) were positive for the in vivo CA test. Higher sensitivity was seen in in vivo CMT (90%) and in vitro CMT (86.9%) assay. Combination of two tests has greater sensitivity than individual tests: in vivo MN + in vivo CA (88.6%); in vivo MN + in vivo CMT (92.5%); and in vivo MN + in vitro CMT (95.6%). Combinations of in vivo or in vitro CMT with other tests provided better sensitivity. In vivo CMT in combination with in vivo CA provided the highest sensitivity (96.7%).
Collapse
Affiliation(s)
- Jacky Bhagat
- Department of Zoology, Goa University, Taleigao Plateau, Goa 403206, India
| |
Collapse
|
6
|
Carlsson H, Aasa J, Kotova N, Vare D, Sousa PFM, Rydberg P, Abramsson-Zetterberg L, Törnqvist M. Adductomic Screening of Hemoglobin Adducts and Monitoring of Micronuclei in School-Age Children. Chem Res Toxicol 2017; 30:1157-1167. [DOI: 10.1021/acs.chemrestox.6b00463] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Henrik Carlsson
- Department
of Environmental Science and Analytical Chemistry, Stockholm University, SE-106
91 Stockholm, Sweden
| | - Jenny Aasa
- Department
of Environmental Science and Analytical Chemistry, Stockholm University, SE-106
91 Stockholm, Sweden
| | | | - Daniel Vare
- Swedish National Food Agency, SE-751
26 Uppsala, Sweden
| | - Pedro F. M. Sousa
- Department
of Environmental Science and Analytical Chemistry, Stockholm University, SE-106
91 Stockholm, Sweden
| | - Per Rydberg
- Department
of Oncology-Pathology, Karolinska Institute, SE-171 77 Stockholm, Sweden
| | | | - Margareta Törnqvist
- Department
of Environmental Science and Analytical Chemistry, Stockholm University, SE-106
91 Stockholm, Sweden
| |
Collapse
|
7
|
Dertinger SD, Torous DK, Hayashi M, MacGregor JT. Flow cytometric scoring of micronucleated erythrocytes: an efficient platform for assessing in vivo cytogenetic damage. Mutagenesis 2010; 26:139-45. [DOI: 10.1093/mutage/geq055] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
|